112 related articles for article (PubMed ID: 11874165)
1. CMV disease in AIDS patients: incidence of CMV disease and relation to survival in a population-based study from Oslo.
Brantsaeter AB; Liestøl K; Goplen AK; Dunlop O; Bruun JN
Scand J Infect Dis; 2002; 34(1):50-5. PubMed ID: 11874165
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus disease in AIDS: the Edinburgh experience.
Cheong I; Flegg PJ; Brettle RP; Welsby PD; Burns SM; Dhillon B; Leen CL; Gray JA
Int J STD AIDS; 1992; 3(5):324-8. PubMed ID: 1327173
[TBL] [Abstract][Full Text] [Related]
3. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
4. Effect of CMV serology and CMV disease on AIDS morbidity and mortality.
Laing RB; Brettle RP; Leen CL
Infection; 1997; 25(4):255. PubMed ID: 9266268
[No Abstract] [Full Text] [Related]
5. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
[TBL] [Abstract][Full Text] [Related]
6. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
J Infect Dis; 1992 Dec; 166(6):1223-7. PubMed ID: 1358986
[TBL] [Abstract][Full Text] [Related]
7. [Digestive cytomegalovirus disease in AIDS patients].
Barberá JR; Capdevila JA; García-Quintana AM; Calicó I; Allende H; Ruiz I; Ocaña I; Pahissa A
Enferm Infecc Microbiol Clin; 1996; 14(7):411-5. PubMed ID: 8991434
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus infection in children with human immunodeficiency virus infection.
Kitchen BJ; Engler HD; Gill VJ; Marshall D; Steinberg SM; Pizzo PA; Mueller BU
Pediatr Infect Dis J; 1997 Apr; 16(4):358-63. PubMed ID: 9109136
[TBL] [Abstract][Full Text] [Related]
9. Distribution and determinants of cytomegalovirus induced end organ disease/s among people living with HIV/AIDS in a poor resource setting: observation from India.
Chakraborty A; Mahapatra T; Mahapatra S; Ansari S; Siddhanta S; Banerjee S; Banerjee D; Sarkar RN; Guha SK; Chakraborty N
PLoS One; 2015; 10(2):e0117466. PubMed ID: 25679798
[TBL] [Abstract][Full Text] [Related]
10. Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS.
d'Arminio Monforte A; Mainini F; Testa L; Vago L; Balotta L; Nebuloni M; Antinori S; Bini T; Moroni M
AIDS; 1997 Mar; 11(4):517-24. PubMed ID: 9084800
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS.
Chevret S; Scieux C; Garrait V; Dahel L; Morinet F; Modaï J; Decazes JM; Molina JM
Clin Infect Dis; 1999 Apr; 28(4):758-63. PubMed ID: 10825035
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: influence on disease expression and survival.
Shepp DH; Moses JE; Kaplan MH
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):460-8. PubMed ID: 8605591
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus.
Gérard L; Leport C; Flandre P; Houhou N; Salmon-Céron D; Pépin JM; Mandet C; Brun-Vézinet F; Vildé JL
Clin Infect Dis; 1997 May; 24(5):836-40. PubMed ID: 9142778
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus colitis in HIV-1-infected patients: a prospective research in 55 patients.
Mentec H; Leport C; Leport J; Marche C; Harzic M; Vildé JL
AIDS; 1994 Apr; 8(4):461-7. PubMed ID: 8011249
[TBL] [Abstract][Full Text] [Related]
15. Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.
Yust I; Fox Z; Burke M; Johnson A; Turner D; Mocroft A; Katlama C; Ledergerber B; Reiss P; Kirk O;
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):550-9. PubMed ID: 15232720
[TBL] [Abstract][Full Text] [Related]
16. Relevance of clinical and laboratory findings in the diagnosis of cytomegalovirus encephalitis in patients with AIDS.
Mussini C; Mongiardo N; Manicardi G; Trenti F; Alessandrì A; Paolillo F; Catania A; Portolani M; Pecorari M; Borghi V; Ficarra G; Cossarizza A; De Rienzo B
Eur J Clin Microbiol Infect Dis; 1997 Jun; 16(6):437-44. PubMed ID: 9248746
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cytomegalovirus disease in the Aquitaine cohort of HIV-infected patients: a retrospective survey, 1987-1993. Groupe d'Epidémilogie Clinique du SIDA en Aquitaine (GECSA).
Saillour F; Bernard N; Ragnaud JM; Morlat P; Blanchard Y; Monlun E; Labouyrie E; Chene G; Dabis F
J Infect; 1997 Sep; 35(2):155-61. PubMed ID: 9354350
[TBL] [Abstract][Full Text] [Related]
18. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.
Casado JL; Arrizabalaga J; Montes M; Martí-Belda P; Tural C; Pinilla J; Gutierrez C; Portu J; Schuurman R; Aguirrebengoa K
AIDS; 1999 Aug; 13(12):1497-502. PubMed ID: 10465073
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors of occurrence of cytomegalovirus disease and impact on survival in the Aquitaine Cohort in France, 1985 to 1994. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
Saillour F; Bernard N; Dequae-Merchadou L; Marimoutou C; Journot V; Dabis F
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):171-8. PubMed ID: 9473020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
